Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-20-077655
Filing Date
2020-06-29
Accepted
2020-06-29 06:30:23
Documents
9
Period of Report
2020-08-04
Effectiveness Date
2020-06-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2023357-1_def14a.htm DEF 14A 1397282
2 GRAPHIC sg_ronaldlombardi-bw.jpg GRAPHIC 1223826
3 GRAPHIC sg_williamcpooi-bw.jpg GRAPHIC 41835
4 GRAPHIC tm2023357d1-bc_netgaapbw.jpg GRAPHIC 960719
5 GRAPHIC tm2023357d1-bc_ceobw.jpg GRAPHIC 778957
6 GRAPHIC tm2023357d1-pc_ceoneobw.jpg GRAPHIC 941764
7 GRAPHIC tm2023357d1-px_signbw.jpg GRAPHIC 691203
8 GRAPHIC tm2023357d1-px_votingbw.jpg GRAPHIC 772699
9 GRAPHIC tm2023357d1-px_annualbw.jpg GRAPHIC 1470561
  Complete submission text file 0001104659-20-077655.txt   10792475
Mailing Address 660 WHITE PLAINS RD. TARRYTOWN NY 10591
Business Address 660 WHITE PLAINS RD. TARRYTOWN NY 10591 (914) 524-6800
Prestige Consumer Healthcare Inc. (Filer) CIK: 0001295947 (see all company filings)

EIN.: 201297589 | Fiscal Year End: 0331
Type: DEF 14A | Act: 34 | File No.: 001-32433 | Film No.: 20995874
SIC: 2834 Pharmaceutical Preparations